C44.71
Basal cell carcinoma of skin of lower limb, including hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Basal cell carcinoma (BCC) is the most common type of skin cancer. When it occurs on the lower limb, including the hip area, it is classified under ICD-10 code C44.71. Usually caused by prolonged sun exposure or other factors damaging the skin cells, BCC tends to grow slowly but can cause significant tissue damage if not treated early. The condition primarily affects fair-skinned individuals and typically appears as a persistent, non-healing sore or a shiny bump that may be pink, red, or brown. Early diagnosis and treatment are key to preventing more serious complications.
Causes & Symptoms
Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from sunlight or tanning beds Fair skin that is more susceptible to UV damage History of sunburns, especially during childhood Chronic skin irritation or injuries Exposure to certain chemicals or radiation A suppressed immune system or immune disorders Hereditary skin conditions that increase skin cancer risk
Key Symptoms: A pearly, shiny bump that may have small blood vessels visible on its surface A flat, firm, pink or flesh-colored scar-like lesion A sore that heals and then reopens or continues to bleed A pink or red raised patch that may resemble eczema or psoriasis Nodules that may become ulcerated or crusted Irregular borders with an area that looks like a sore or a wound that won't heal Possible sensation of tenderness or itchiness around the lesion
Diagnostic & Treatment
Diagnosis Path: Diagnosing basal cell carcinoma involves a thorough skin examination by a healthcare professional. If a suspicious lesion is identified, a biopsy will typically be performed to confirm the diagnosis. The biopsy involves removing a small sample of the lesion for laboratory analysis. Additional imaging tests like dermoscopy, high-frequency ultrasound, or MRI may be used if deeper tissue involvement or extensive spread is suspected. Accurate diagnosis helps determine the most appropriate treatment plan and assess whether the cancer has spread beyond the initial site.
Treatment Protocols: Treating basal cell carcinoma generally involves removing the cancerous lesion and surrounding tissue to prevent recurrence. Options include: - Surgical excision: Cutting out the tumor along with a small margin of healthy tissue. - Mohs micrographic surgery: A precise technique that removes the cancer layer by layer, examining each under the microscope until no abnormal cells remain. - Curettage and electrodessication: Scraping away the lesion and using electric pulses to destroy remaining cancer cells. - Cryotherapy: Freezing the lesion with liquid nitrogen to destroy the abnormal tissue. - Topical medications: Such as imiquimod cream or 5-fluorouracil for superficial lesions. - Radiation therapy: Used in cases where surgery is not suitable. Follow-up care includes regular skin examinations to monitor for recurrence or new lesions. Early management improves outcomes and helps prevent more serious skin damage or spread to other areas.
Clinical Advice & FAQs
Billing Guidance
Is C44.71 a billable ICD-10 code?
Yes, C44.71 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C44.71?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of lower limb, including hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference